摘要
目的 :比较观察妊娠合并贫血患者应用生血宁片和琥珀酸亚铁片治疗的效果。方法 :将90例妊娠合并贫血患者随机分为A组(琥珀酸亚铁片治疗)和B组(生血宁片治疗)各45例。治疗3月,比较两组贫血相关指标、不良反应、总有效率、妊娠结局情况。结果:A组总有效率、血红蛋白和血清铁蛋白水平、红细胞计数均明显优于B组(P<0.05);A组药物不良反应、不良妊娠结局均比B组高(P <0.05)。结论 :对于妊娠合并贫血患者,琥珀酸亚铁片的疗效明显优于生血宁片,但是生血宁片安全性更高。对于严重贫血患者,两种药物联合使用有互补作用,优化整体治疗效果。
Objective: To compare the effect of Shengxuening tablet and ferrous succinate tablet in the treatment of pregnancy with anemia. Methods: Ninety pregnant women with anemia were randomly divided into group A (treated with ferrous succinate tablets) and group B (treated with Shengxuening tablets) with 45 cases each. Anemia-related indicators, adverse reactions, total effective rate and pregnancy outcomes were compared between the two groups at 3 months after treatment. Results: The total effective rate, the levels of hemoglobin and serum ferritin, the red blood cell count, and the incidence of adverse drug reactions and adverse pregnancy outcomes were significantly higher in group A than group B (P<0.05). Conclusion: For pregnant women with anemia, the efficacy of ferrous succinate tablets is better than Shengxuening tablets but the safety of Shengxuening tablets is higher. For patients with severe anemia, the combination of the two drugs can complement each other and optimize the overall treatment effect.
作者
贾爱英
王雪萍
JIA Aiying;WANG Xueping(Department of Gynaecology and Obstetrics, Anyang Hospital of Traditional Chinese Medicine, He’nan Anyang 455112, China)
出处
《上海医药》
CAS
2019年第9期40-42,62,共4页
Shanghai Medical & Pharmaceutical Journal
关键词
妊娠合并贫血
琥珀酸亚铁片
生血宁片
疗效
pregnancy with anemia
ferrous succinate tablets
Shengxuening tablet
curative effect
